Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

3 key requirements for AI in healthcare to reach its full potential

AI could change healthcare forever. But for the technology to reach its full potential, researchers must make sure they go about things the right way.

Thumbnail

The role of medical debt in American bankruptcy

Medical debt is a significant factor in the reasons Americans file for bankruptcy, and Americans facing major health scares are also likely to face financial setbacks.

Thumbnail

Justice Department sues CVS subsidiary Omnicare

A CVS Health subsidiary, Omnicare, is facing a lawsuit from the Department of Justice over allegations the company defrauded government health programs by providing prescription drugs to thousands of long-term care facilities without proper prescriptions.

Thumbnail

HHS proposals aim to boost organ donation supply

HHS has issued a set of two proposed rules aimed at improving the availability of organs for the 113,000 Americans on waitlists for transplants.

Thumbnail

Humana acquiring hospice pharmacy Enclara Healthcare

Louisville-based Humana, the nation’s third-largest health insurance provider, is acquiring a large privately held hospice pharmacy and benefit management providers, Enclara Healthcare.

Thumbnail

Top 10 healthiest states in America

Vermont is ranked as the nation’s healthiest state, according to UnitedHealth Group, which released its annual population health rankings. Mississippi trails the country as the least healthy state in the nation.

Thumbnail

Digital health pharma deals reach new high in 2019

Seeking to accelerate technological capabilities, healthcare investors have been snapping up AI and machine learning companies and driving up digital health M&A in the pharmaceutical and biotechnology space as a result.

Thumbnail

FDA workshop to explore AI’s impact on imaging

AI’s impact on medical imaging continues to be one of the most significant trends of the last several years, and now the FDA has announced a public workshop focused on that very subject.

Around the web

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

One product is being pulled from the market, and the other is receiving updated instructions for use.

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?